Stock & Company Details
Context Therapeutics Inc $CNTX
Price:
N/A
N/A
92M
$19M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.42
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CNTX technical indicators
Latest Context Therapeutics Inc (CNTX) indicator readings as of 2026-10-29.
CNTX's 14-day RSI is 21.7, in oversold territory. At $0.20 it is trading 86.2% below its 200-day moving average of $1.46, and below its 50-day average of $0.33. Price sits near the lower Bollinger Band ($0.18 to $0.34). ADX reads 47.1, indicating a trending market.
Overview
Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.
Finance Bot
Ask your questions
Start by typing a question below.
